货号:GS40802
Vopratelimab (JTX-4014) is an investigational humanized monoclonal antibody that targets and acts as an agonist of the Inducible T-cell Co-stimulator (ICOS). It is being developed for cancer immunotherapy, aiming to enhance anti-tumor T-cell responses by selectively activating and expanding tumor-reactive T cells that express ICOS.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯